Centre of excellence for the production and development and further processing of pellets and modified release dosage forms.

At Bielefeld, NextPharma offers two pelleting technologies recognised for robustness and reproducibility: pelleting via extrusion and via layering of non-pareils. Our equipment is fully validated to handle solvents with maximum safety. 

Capsules, tablets and stick pack production can be handled with high speed equipment to formulate pellets in final dosage forms.

The following services are offered:

Pharmaceutical Development

A strong know how has been developed with highly-skilled scientists to develop all types of modified release formulations:

  • Pharmaceutical formulation development
  • Scale-up (pilot-scale, production-scale)
  • Validation
  • Manufacturing of stability batches
  • Galenic optimisation of existing formulae
  • Registration services

Contract Analytics

Being our centre of excellence for analytics, Bielefeld can provide the highest scientific support for local development, but even assist when necessary other Nextpharma sites with the following services:

  • Analytical development
  • Validation
  • Stability testing / storage
  • Quality control
  • Market release

Commercial Manufacturing and Packaging

Mixing/Blending 600 tonnes
Pellets 500 tonnes
Tabletting 800m tablets
Encapsulation 350m capsules
Coating 600 tonnes
Stick Packs 50m packs
Manufacturing 3,400 m²
Regulatory status Anvisa (Brazil), EMA, FDA (USA)

Site contact information

Address

NextPharma
Reichenberger Str. 43
D-33605 Bielefeld
Germany

Fax

+49-521-20 45 51